AUTHOR=Shimizu Toshio , Powderly John , Abdul Razak Albiruni , LoRusso Patricia , Miller Kathy D. , Kao Steven , Kongpachith Sarah , Tribouley Catherine , Graham Michelle , Stoll Brian , Patel Maulik , Sahtout Mohammad , Blaney Martha , Leibman Rachel , Golan Talia , Tolcher Anthony 

TITLE=First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP:TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors

JOURNAL=Frontiers in Oncology

VOLUME=14

YEAR=2024

URL=https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1376551

DOI=10.3389/fonc.2024.1376551

ISSN=2234-943X